Resonance light scattering technology-based toolkit is part of a fully integrated detection system, promising the most sensitive detection of gene expression
Genicon Sciences has announced it has launched its second commercially available resonance light scattering (RLS) technology product - an RLS-based two-colour nucleic acid microarray toolkit for gene expression analysis.
The two-colour nucleic acid microarray toolkit is an ultra-sensitive, multi-colour assay that is capable of deriving more data from small amounts of biological material and identifying expressed genes that are undetectable by current methods and critical to clinical diagnostics and the drug discovery process.
The toolkit is part of a fully integrated detection system, the RLS Array Detection System that provides researchers with a total assay platform for gene expression analysis.
The system includes the two-colour nucleic acid microarray toolkit, the GSD-501 RLS detection and imaging instrument, and ArrayVision RLS image analysis software.
The RLS Array Detection System is available through Genicon Sciences, and will soon be available through Genicon's co-distribution partner, Qiagen, as the HiLight array system.
Genicon Sciences's Resonance Light Scattering (RLS) Technology is a reproducible, ultra-sensitive, non-fluorescent signal generation and detection technology based on nanometre-sized metal colloidal particles that can be used as ultra-sensitive biological labels in a wide variety of analytical bioassays critical in the drug discovery process and clinical diagnostics.
When illuminated with configured white light, RLS Particles generate intense, coloured, scattered light signals. The sensitivity of RLS Technology allows researchers to analyse nucleic acids, proteins and biomarkers that are not normally detected by current standard assay microarray methods, enabling results utilising as little as one-tenth the starting material. "Our goal is to provide open access to our RLS Technology through products that benefit and meet the needs of the life science research community," said Patrick Mallon, president and CEO for Genicon Sciences.
"It's exciting for us to commercialise another product that readily aids researchers in identifying and routinely studying differentially expressed genes in a manner that was not previously possible." The two-colour nucleic acid microarray toolkit and the one-colour nucleic acid microarray toolkit are designed for the detection of nucleic acids and are the first commercial releases from Genicon Sciences's portfolio of integrated RLS-based assay products, services and solutions currently under development.
Future products will enable users to perform microarrays and other bioassays for nucleic acids, proteins, cells, and small and large molecule drugs.
